Zhang Zhongheng, Hong Yucai
Department of Emergency Medicine, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China.
Oncotarget. 2017 Jul 25;8(30):49637-49645. doi: 10.18632/oncotarget.17870.
There are several disease severity scores being used for the prediction of mortality in critically ill patients. However, none of them was developed and validated specifically for patients with severe sepsis. The present study aimed to develop a novel prediction score for severe sepsis.
A total of 3206 patients with severe sepsis were enrolled, including 1054 non-survivors and 2152 survivors. The LASSO score showed the best discrimination (area under curve: 0.772; 95% confidence interval: 0.735-0.810) in the validation cohort as compared with other scores such as simplified acute physiology score II, acute physiological score III, Logistic organ dysfunction system, sequential organ failure assessment score, and Oxford Acute Severity of Illness Score. The calibration slope was 0.889 and Brier value was 0.173.
The study employed a single center database called Medical Information Mart for Intensive Care-III) MIMIC-III for analysis. Severe sepsis was defined as infection and acute organ dysfunction. Clinical and laboratory variables used in clinical routines were included for screening. Subjects without missing values were included, and the whole dataset was split into training and validation cohorts. The score was coined LASSO score because variable selection was performed using the least absolute shrinkage and selection operator (LASSO) technique. Finally, the LASSO score was evaluated for its discrimination and calibration in the validation cohort.
The study developed the LASSO score for mortality prediction in patients with severe sepsis. Although the score had good discrimination and calibration in a randomly selected subsample, external validations are still required.
有几种疾病严重程度评分用于预测危重症患者的死亡率。然而,这些评分均未专门针对严重脓毒症患者开发和验证。本研究旨在开发一种用于严重脓毒症的新型预测评分。
共纳入3206例严重脓毒症患者,其中1054例死亡,2152例存活。与其他评分(如简化急性生理学评分II、急性生理学评分III、逻辑器官功能障碍系统、序贯器官衰竭评估评分和牛津急性疾病严重程度评分)相比,LASSO评分在验证队列中显示出最佳的区分度(曲线下面积:0.772;95%置信区间:0.735 - 0.810)。校准斜率为0.889,Brier值为0.173。
本研究采用一个名为重症监护医学信息数据库III(MIMIC-III)的单中心数据库进行分析。严重脓毒症定义为感染和急性器官功能障碍。纳入临床常规使用的临床和实验室变量进行筛选。纳入无缺失值的受试者,并将整个数据集分为训练队列和验证队列。该评分被命名为LASSO评分,因为变量选择是使用最小绝对收缩和选择算子(LASSO)技术进行的。最后,在验证队列中评估LASSO评分的区分度和校准情况。
本研究开发了用于预测严重脓毒症患者死亡率的LASSO评分。尽管该评分在随机选择的子样本中具有良好的区分度和校准,但仍需要外部验证。